1700123O20Rik Activators
1700123O20Rik activators encompass a spectrum of chemical compounds that indirectly stimulate the functional activity of 1700123O20Rik by modulating various signaling pathways. Forskolin, by increasing intracellular cAMP, activates PKA, which can enhance the phosphorylation status and activity of 1700123O20Rik, implicating a role in cellular regulatory processes. PMA, through PKC activation, may lead to the phosphorylation and subsequent activation of 1700123O20Rik, integrating it into specific signaling cascades. Ionomycin and A23187, both calcium ionophores, elevate cytosolic calcium levels, thereby activating calcium-dependent proteins that could enhance the regulatory functions of 1700123O20Rik. This gene codes for a particular protein that plays a role in cellular processes, and its activation can have various effects on cellular functions. The initial step in the identification of these activators involves high-throughput screening techniques that test a wide array of chemical compounds for their ability to stimulate gene expression.
When a compound successfully activates the promoter, the luciferase enzyme is expressed, producing a luminescent signal that can be quantitatively measured. Compounds that lead to a marked increase in luminescence are flagged for further study as potential activators of the 1700123O20Rik gene. Compounds that have been identified as potential 1700123O20Rik Activators are subjected to a comprehensive verification process. Quantitative PCR (qPCR) is one of the pivotal techniques used to confirm the ability of these compounds to enhance the transcription of the 1700123O20Rik gene. Another essential technique is Western blotting, which is used to assess whether the increased mRNA levels translate to an increase in protein production. This method provides insights into the stability of the protein and whether the activator influences post-translational modifications.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). By activating PKC, PMA can modulate signaling pathways that rely on PKC-mediated phosphorylation. If 1700123O20Rik is a protein that is functionally enhanced by PKC phosphorylation, or if it participates in a signaling cascade downstream of PKC, PMA could indirectly enhance the activity of 1700123O20Rik through targeted phosphorylation events. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Calcium ions are crucial secondary messengers in various signaling pathways, including those that involve calmodulin-dependent kinases or calcineurin. If 1700123O20Rik's activity is modulated by calcium signaling, the elevation of intracellular calcium by ionomycin could enhance the protein's functional activity through calcium-dependent activation mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K). By inhibiting PI3K, this compound decreases the levels of phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and can reduce AKT phosphorylation, affecting cell survival and growth signals. If 1700123O20Rik is involved in a pathway that is negatively regulated by PI3K/AKT signaling, inhibition by LY294002 could relieve this negative regulation, thereby enhancing the activity of 1700123O20Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a potent inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium concentrations. If 1700123O20Rik is calcium-regulated or part of a calcium-dependent signaling pathway, the increase in cytosolic calcium caused by thapsigargin could indirectly enhance the activity of 1700123O20Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases. If the functional activity of 1700123O20Rik is suppressed by a kinase that is inhibited by EGCG, then this compound could lift the suppression, leading to an enhancement of 1700123O20Rik's activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, which might reduce competitive phosphorylation events, thereby potentially enhancing the activity of 1700123O20Rik through its signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similarly to ionomycin, raising intracellular calcium levels and activating calcium-dependent pathways that can enhance the activity of 1700123O20Rik. | ||||||